The biosecure act throws up exciting opportunities for quality API companies in India. Already Syngene has a strong relationship with BMS and Neuland is associated Karuna Therapeutics.
| Subscribe To Our Free Newsletter |
Midhun’s Investment journey and Space to organize investment ideas
